LncRNAs expression signatures of renal clear cell carcinoma revealed by microarray

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Yu, Gan ^a   Yao, Weimin ^a   Wang, Ji ^b   Ma, Xin ^c   Xiao, Wei ^a   Li, Heng ^a   Xia, Ding ^a   Yang, Yang ^a   Deng, Kangli ^a   Xiao, Haibing ^a   Wang, Bohan ^a   Guo, Xiaolin ^a   Guan, Wei ^a   Hu, Zhiquan ^a   Bai, Yinqi ^d   Xu, Hua ^a   Liu, Jihong ^a   Zhang, Xu ^c   Ye, Zhangqun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d BGI SHENZHEN   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; MESSENGER RNA; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

ARTICLE; CANCER TISSUE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; LONG NONCODING RNA GENE; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION;

CARCINOMA, RENAL CELL; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; KIDNEY NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA, LONG UNTRANSLATED; RNA, MESSENGER; UP-REGULATION;

EID: 84864653060     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042377     Document Type: Article

References (42)

1. Chow WH, Dong LM, Devesa SS, ((2010)) Epidemiology and risk factors for kidney cancer. Nat Rev Urol 7:245-257.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. ((2010)) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917.
3. Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, et al. ((1977)) Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyons, France. Int J Cancer 20:680-688.
4. Azeem K, Kollarova H, Horakova D, Magnuskova S, Janout V, ((2011)) Genetic syndromes associated with renal cell carcinoma: a review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 155:231-238.
5. Oosterwijk E, Rathmell WK, Junker K, Brannon AR, Pouliot F, et al. ((2011)) Basic research in kidney cancer. Eur Urol 60:622-633.
6. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, et al. ((1994)) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852-2855.
7. Iliopoulos O, Kibel A, Gray S, Kaelin WG Jr, ((1995)) Tumour suppression by the human von Hippel-Lindau gene product. Nat Med 1:822-826.
8. Kondo K, Klco J, Nakamura E, Lechpammer M, Kaelin WG Jr, ((2002)) Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell 1:237-246.
9. Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, et al. ((2010)) Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463:360-363.
10. Varela I, Tarpey P, Raine K, Huang D, Ong CK, et al. ((2011)) Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 469:539-542.
11. van Rooijen E, Voest EE, Logister I, Bussmann J, Korving J, et al. ((2010)) von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish. Dis Model Mech 3:343-353.
12. Ponting CP, Oliver PL, Reik W, ((2009)) Evolution and functions of long noncoding RNAs. Cell 136:629-641.
13. White NM, Bao TT, Grigull J, Youssef YM, Girgis A, et al. ((2011)) miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol 186:1077-1083.
14. Wang KC, Chang HY, ((2011)) Molecular mechanisms of long noncoding RNAs. Mol Cell 43:904-914.
15. Wapinski O, Chang HY, ((2011)) Long noncoding RNAs and human disease. Trends Cell Biol 21:354-361.
16. Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, et al. ((2004)) Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet 36:40-45.
17. Okazaki Y, Furuno M, Kasukawa T, Adachi J, Bono H, et al. ((2002)) Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 420:563-573.
18. Tupy JL, Bailey AM, Dailey G, Evans-Holm M, Siebel CW, et al. ((2005)) Identification of putative noncoding polyadenylated transcripts in Drosophila melanogaster. Proc Natl Acad Sci U S A 102:5495-5500.
19. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS, ((2010)) Non-coding RNAs: regulators of disease. J Pathol 220:126-139.
20. Wilusz JE, Sunwoo H, Spector DL, ((2009)) Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 23:1494-1504.
21. Orom UA, Derrien T, Beringer M, Gumireddy K, Gardini A, et al. ((2010)) Long noncoding RNAs with enhancer-like function in human cells. Cell 143:46-58.
22. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, et al. ((2007)) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129:1311-1323.
23. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, et al. ((2009)) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 106:11667-11672.
24. Guttman M, Amit I, Garber M, French C, Lin MF, et al. ((2009)) Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458:223-227.
25. Dall'Oglio MF, Coelho RF, Leite KR, Sousa-Canavez JM, Oliveira PS, et al. ((2010)) Gene expression profile of renal cell carcinoma clear cell type. Int Braz J Urol 36: 410-418; discussion 418-419.
26. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, et al. ((2010)) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464:1071-1076.
27. Hessels D, Schalken JA, ((2009)) The use of PCA3 in the diagnosis of prostate cancer. Nat Rev Urol 6:255-261.
28. Ifere GO, Ananaba GA, ((2009)) Prostate cancer gene expression marker 1 (PCGEM1): a patented prostate- specific non-coding gene and regulator of prostate cancer progression. Recent Pat DNA Gene Seq 3:151-163.
29. Nagano T, Mitchell JA, Sanz LA, Pauler FM, Ferguson-Smith AC, et al. ((2008)) The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 322:1717-1720.
30. Sutherland HF, Wadey R, McKie JM, Taylor C, Atif U, et al. ((1996)) Identification of a novel transcript disrupted by a balanced translocation associated with DiGeorge syndrome. Am J Hum Genet 59:23-31.
31. Zhao H, Shen J, Medico L, Wang D, Ambrosone CB, et al. ((2010)) A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One 5:e13735.
32. Plath K, Mlynarczyk-Evans S, Nusinow DA, Panning B, ((2002)) Xist RNA and the mechanism of X chromosome inactivation. Annu Rev Genet 36:233-278.
33. Koerner MV, Pauler FM, Huang R, Barlow DP, ((2009)) The function of non-coding RNAs in genomic imprinting. Development 136:1771-1783.
34. De Santa F, Barozzi I, Mietton F, Ghisletti S, Polletti S, et al. ((2010)) A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol 8:e1000384.
35. Kim TK, Hemberg M, Gray JM, Costa AM, Bear DM, et al. ((2010)) Widespread transcription at neuronal activity-regulated enhancers. Nature 465:182-187.
36. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, et al. ((2010)) A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142:409-419.
37. Ponjavic J, Oliver PL, Lunter G, Ponting CP, ((2009)) Genomic and transcriptional co-localization of protein-coding and long non-coding RNA pairs in the developing brain. PLoS Genet 5:e1000617.
38. Ebisuya M, Yamamoto T, Nakajima M, Nishida E, ((2008)) Ripples from neighbouring transcription. Nat Cell Biol 10:1106-1113.
39. Sproul D, Gilbert N, Bickmore WA, ((2005)) The role of chromatin structure in regulating the expression of clustered genes. Nat Rev Genet 6:775-781.
40. Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS, ((2008)) Specific expression of long noncoding RNAs in the mouse brain. Proc Natl Acad Sci U S A 105:716-721.
41. Ren S, Peng Z, Mao JH, Yu Y, Yin C, et al. ((2012)) RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res.
42. Bertozzi D, Iurlaro R, Sordet O, Marinello J, Zaffaroni N, et al. ((2011)) Characterization of novel antisense HIF-1alpha transcripts in human cancers. Cell Cycle 10:3189-3197.